Oncologists can use colorectal cancer patients' own immune system to boost the effects of chemotherapy and increase progression-free survival, according to Phase III study results presented…
A dendritic cell vaccine personalised for each individual based on the patient's own tumour may increase median survival time in those with a deadly form of brain cancer called glioblastoma,…
Chemotherapy drug resistance contributes to treatment failure in more than 90 percent of metastatic cancers. Overcoming this hurdle would significantly improve cancer survival rates…
A group of researchers from EPFL's Global Health Institute (GHI) and Inserm (Institut National de la Sante et de la Recherche Medicale, the French government agency for biomedical research)…
Bowel cancer patients whose tumours contain defects in specific DNA repair systems are much less likely to experience tumour recurrence post surgery, results from a major clinical study…
An analysis conducted by Ohio State University cancer researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is…
A new peptide developed by researchers in Temple University's College of Science and Technology has demonstrated efficacy against triple negative breast cancer…
Researchers from Boston University School of Medicine (BUSM) have found that patients with node negative T3 and T4 non-small lung cancer who underwent chemotherapy before surgery had…
A new analysis has found that supplementing the diet with fish oil may prevent muscle and weight loss that commonly occurs in cancer patients who undergo chemotherapy. Published early…
A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an…